Portfolio company
Rocket Isotopes AG
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company produces medical radioisotopes for pharmaceutical firms and clinical trials to facilitate radioligand therapies for cancer patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Actithera
This biotechnology company develops targeted radioligand therapies to treat cancer patients by delivering radioactive isotopes directly to solid tumours.
ROTOP
This company manufactures radiopharmaceuticals and cold kits for diagnostic imaging and cancer therapy, serving hospitals, clinics, and pharmaceutical research partners globally.
Full-Life Technologies
This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.
AdvanCell
AdvanCell develops targeted alpha therapies and isotope generators to treat cancer patients through a vertically integrated radiopharmaceutical platform.
Astral Systems
The company develops compact nuclear fusion reactors for healthcare providers and researchers to produce medical radioisotopes for cancer diagnosis and treatment.
ROTOP Pharmaka GmbH
This company develops and manufactures radiopharmaceuticals for diagnostic imaging and therapy, serving hospitals, clinics and research institutions globally.
Nuclidium
This clinical-stage company develops copper-based radiopharmaceuticals for the diagnosis and treatment of cancer patients.
Alpha-9 Theranostics
This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.